ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.

Bergese, Sergio D; Brzezinski, Marek; Hammer, Gregory B; Beard, Timothy L; Pan, Peter H; Mace, Sharon E; Berkowitz, Richard D; Cochrane, Kristina; Wase, Linda; Minkowitz, Harold S; Habib, Ashraf S

Bergese, Sergio D; Brzezinski, Marek; Hammer, Gregory B; Beard, Timothy L; Pan, Peter H; Mace, Sharon E; Berkowitz, Richard D; Cochrane, Kristina; Wase, Linda; Minkowitz, Harold S; Habib, Ashraf S.

Afiliación

Bergese SD; School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Brzezinski M; School of Medicine, University of California San Francisco, VA Medical Center, San Francisco, CA, USA.
Hammer GB; Stanford University School of Medicine, Stanford, CA, USA.
Beard TL; Clinical Research, Summit Medical Group/Bend Memorial Clinic, Bend, OR, USA.
Pan PH; Wake Forest School of Medicine, Winston-Salem, NC, USA.
Mace SE; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USA.
Berkowitz RD; Phoenix Clinical Research, Tamarac, FL, USA.
Cochrane K; Trevena, Inc., Chesterbrook, PA, USA.
Wase L; Trevena, Inc., Chesterbrook, PA, USA.
Minkowitz HS; HD Research Corporation, Houston, TX, USA.
Habib AS; Duke University Medical Center, Durham, NC, USA.

J Pain Res ; 12: 3113-3126, 2019.

Article en En | MEDLINE | ID: mdl-31814753

Palabras clave

acute pain; analgesia; clinical trial; patient-controlled

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Pain Res Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google